Background Despite remarkable progress, HIV's influence on global health remains firm,
demanding continued attention. Understanding the effectiveness of third-line antiretroviral …

Background Despite significant reductions in mother-to-child HIV-1 transmission risks due to
the advancements and scale-up of antiretroviral therapy (ART), the global burden of HIV-1 …

Ebola virus disease (EVD), caused by infection with Ebola virus, results in severe, acute
illness with a high mortality rate. As the incidence of outbreaks of EVD increases and with …

Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) continue to be global
public health issues. Globally, about 39.9 million persons live with HIV in 2023, according to …

Exercise is vital in managing sarcopenia in people living with HIV (PLWH). This study
explores the role of exercise in reducing sarcopenia in HIV patients. A systematic search of …

Background The emergence of HIV drug resistance presents a substantial challenge.
Current antiretroviral treatments, along with current classes, face the danger of becoming …

The complete and prolonged suppression of viral load is the primary objective of HAART in
people living with HIV. Some people may experience therapeutic failure, while others may …

Cell‐based therapies represent a major advancement in the treatment and management of
HIV/AIDS, with a goal to overcome the limitations of traditional antiretroviral therapy (ART) …

People with HIV (PWH) may be more susceptible to SARS-CoV-2 infection and worse
clinical outcomes. We investigated the disparity in SARS-CoV-2 vaccination coverage …

Kerra™, a Thai traditional herbal medicine derived from the “Tak-Ka-Si-La Scripture” and
composed of nine medicinal plants, has demonstrated potential antiviral properties against …